BIOMAT Database Logo BIOMAT Database Logo

Somatic mutation analysis in melanoma using targeted next generation sequencing. 2017

Allen P Miraflor, and Francine B de Abreu, and Jason D Peterson, and Scott A Turner, and Christopher I Amos, and Gregory J Tsongalis, and Shaofeng Yan
Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, United States.

Advanced stage malignant melanoma often responds poorly to therapy with low survival rates. New therapeutic approaches are based upon a growing understanding of the underlying molecular abnormalities. We demonstrate the feasibility of a next generation sequencing (NGS) assay, which targets hotspots in 50 cancer genes, to assess genotypes that may influence therapeutic selection and response. DNA was extracted from formalin fixed paraffin embedded (FFPE) melanoma specimens to create multiplexed libraries which were sequenced. Of the 121 cases, BRAF mutations were present in 48 cases (40%) and NRAS mutations in 24 cases (20%). We identified other gene variants in 20 BRAF-mutated cases. Additional gene variants were also identified in the 57 BRAF wild-type cases. Four patients harbored different gene mutations at metastatic sites as compared to their primary lesions or metastasis from different sites. Concurrent gene variants may provide additional targets for future therapies and may suggest alternative mechanisms of secondary resistance.

UI MeSH Term Description Entries
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes

Related Publications

Allen P Miraflor, and Francine B de Abreu, and Jason D Peterson, and Scott A Turner, and Christopher I Amos, and Gregory J Tsongalis, and Shaofeng Yan
Uveal melanoma hepatic metastases mutation spectrum analysis using targeted next-generation sequencing of 400 cancer genes.
April 2015, The British journal of ophthalmology,
Allen P Miraflor, and Francine B de Abreu, and Jason D Peterson, and Scott A Turner, and Christopher I Amos, and Gregory J Tsongalis, and Shaofeng Yan
Somatic mutation profiling of liver and biliary cancer by targeted next generation sequencing.
November 2018, Oncology letters,
Allen P Miraflor, and Francine B de Abreu, and Jason D Peterson, and Scott A Turner, and Christopher I Amos, and Gregory J Tsongalis, and Shaofeng Yan
Potential Mutations in Uveal Melanoma Identified Using Targeted Next-Generation Sequencing.
January 2019, Journal of Cancer,
Allen P Miraflor, and Francine B de Abreu, and Jason D Peterson, and Scott A Turner, and Christopher I Amos, and Gregory J Tsongalis, and Shaofeng Yan
[Mutation analysis for two hypophosphatasia families with targeted next-generation sequencing].
December 2016, Zhonghua yi xue za zhi,
Allen P Miraflor, and Francine B de Abreu, and Jason D Peterson, and Scott A Turner, and Christopher I Amos, and Gregory J Tsongalis, and Shaofeng Yan
Analysis of targeted somatic mutations in pleomorphic carcinoma of the lung using next-generation sequencing technique.
August 2020, Thoracic cancer,
Allen P Miraflor, and Francine B de Abreu, and Jason D Peterson, and Scott A Turner, and Christopher I Amos, and Gregory J Tsongalis, and Shaofeng Yan
Mutation Detection in Patients with Retinal Dystrophies Using Targeted Next Generation Sequencing.
January 2016, PloS one,
Allen P Miraflor, and Francine B de Abreu, and Jason D Peterson, and Scott A Turner, and Christopher I Amos, and Gregory J Tsongalis, and Shaofeng Yan
Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma.
May 2018, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
Allen P Miraflor, and Francine B de Abreu, and Jason D Peterson, and Scott A Turner, and Christopher I Amos, and Gregory J Tsongalis, and Shaofeng Yan
Pitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencing.
October 2016, BMC medical genomics,
Allen P Miraflor, and Francine B de Abreu, and Jason D Peterson, and Scott A Turner, and Christopher I Amos, and Gregory J Tsongalis, and Shaofeng Yan
Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis.
January 2015, International journal of endocrinology,
Allen P Miraflor, and Francine B de Abreu, and Jason D Peterson, and Scott A Turner, and Christopher I Amos, and Gregory J Tsongalis, and Shaofeng Yan
Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing.
January 2015, PloS one,
Copied contents to your clipboard!